United States Biopsy Devices Market Overview
Base Year: 2024
Forecast Years: 2025-2033
Historical Years: 2019-2024
Market Size in 2024: USD 963.7 Million
Market Forecast in 2033: USD 1,273.2 Million
Market Growth Rate: 2.99% (2025-2033)
The United States biopsy devices market is experiencing steady growth, driven by the rising prevalence of chronic diseases such as cancer, continuous technological advancements in biopsy guidance systems, favorable reimbursement policies, and the presence of a robust healthcare infrastructure. Biopsy devices are medical instruments designed to extract tissue or cell samples from various body parts for diagnostic purposes. These devices play a pivotal role in the early detection and diagnosis of cancer, infectious diseases, and other medical conditions.
United States Biopsy Devices Market Trends and Drivers:
The United States biopsy devices market is growing steadily. The healthcare system is focusing on early detection and accurate disease diagnosis. Biopsies are essential for identifying chronic conditions, especially cancer. Hospitals and diagnostic centers are now using better, less invasive biopsy technologies. Cancer rates are increasing in many groups.
Needle and surgical biopsies are now used in oncology, pulmonology, and gastroenterology. Better image-guided biopsy systems help doctors take precise tissue samples. They also make it easier for patients. Biopsy devices now work better with ultrasound, MRI, and stereotactic imaging. This change leads to improved accuracy and outcomes.
Healthcare providers are integrating advanced biopsy systems into their diagnostic workflows. This shift aligns with the move toward precision medicine. These technologies help pathologists see tumor behavior, tissue changes, and genetic markers immediately. This improves treatment planning. The U.S. healthcare system has a strong foundation. This supports the use of advanced biopsy devices.
Also, good reimbursement policies and funding help. Schools and research groups are working with manufacturers. They are testing new biopsy technologies to check if they work well in clinics. The focus on outpatient care is boosting the use of small, portable, and affordable biopsy tools. These tools are now common in ambulatory surgical centers and specialty clinics. These trends improve access to timely diagnostics in underserved areas. They also strengthen the role of biopsy devices in boosting public health.
The market is also expanding into new application areas beyond oncology. Breast, prostate, lung, and colorectal biopsies are still important. There is a rising need for biopsy solutions. This demand comes from areas like musculoskeletal disorders, skin issues, and infections.
Manufacturers are making multi-modality platforms and easy-to-use tools. These fit well in clinical settings. New biopsy needles, better ways to extract samples, and robotic help are making procedures easier. As technology boosts biopsy devices, the U.S. market is becoming a leader in global diagnostics.
United States Biopsy Devices Market Report Segmentation:
The report provides an analysis of the key trends in each segment of the market, including the United States biopsy devices market size, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on procedure type, product, application, guidance technique, end user, and region.
Procedure Type Insights:
- Surgical Biopsy
- Needle Biopsy
Product Insights:
- Biopsy Guidance Systems
- Needle-Based Biopsy Guns
- Biopsy Needles
- Biopsy Forceps
- Others
Application Insights:
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Others
Guidance Technique Insights:
- Ultrasound-guided Biopsy
- Stereotactic-guided Biopsy
- MRI-guided Biopsy
- Others
End User Insights:
- Hospitals and Clinics
- Academic and Research Institutes
- Others
Regional Insights:
- Northeast
- Midwest
- South
- West
For an in-depth analysis, you can refer to a sample copy of the report:
https://www.imarcgroup.com/united-states-biopsy-devices-market/requestsample
Competitive Landscape
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Highlights of the Report:
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current, and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note:
If you need specific information that is not currently within the scope of the report, we can provide it as part of the customization.
About Us:
IMARC Group is a leading market research company offering management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic, and technological developments for pharmaceutical, industrial, and high-technology business leaders. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No: (D) +91 120 433 0800
United States: +1-631-791-1145
